Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | ELDNEledon Pharmaceuticals, Inc.FY2016 · Dec |
|---|---|
| Revenue | $0.00 |
| Revenue, yoy | — |
| Net income | $45.62M |
| Net income, yoy | −26.1% |
| Net margin | — |
| Free cash flow | $4.93M |
| FCF margin | — |
| EPS, diluted | $0.52 |
Add another company.